| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XX52 | B | Venetoclax - 100mg | 9175 | 55117/1 | VENCLEXTA | 100mg | 120 | Tablet | Oral | Interpharma S.A.L. | Abbvie Inc | USA | 707,858,935 L.L | 2.44 | E2 | Abbvie Inc | USA | 6/3/2026 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XX52 | G | Venetoclax - 100mg | 12611 | 38125/1 | XERVEXTA | 100mg | 120 | Tablet, film coated | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC, Sahab, Industrial City, Amman | Jordan | 407,797,574 L.L | 2.44 | E2 | Hikma Pharmaceuticals | 6/3/2026 | ||
| L01XX52 | B | Venetoclax - 100mg | 9175/388 | 55117/1 | VENCLEXTA | 100mg | 120 | Tablet | Oral | Interpharma S.A.L. | Abbvie Inc | USA | L.L | 2.44 | E2 | Abbvie Inc | USA | 6/3/2026 |
